Your email has been successfully added to our mailing list.

×
0 -0.0019342359767892 0.0019342359767892 -0.000518375241779526 -0.00776789168278534 -0.00389941972920695 -0.00116054158607354 0.0192417794970986
Stock impact report

Is This Gene-Editing Stock Doomed? [The Motley Fool]

Sangamo Therapeutics, Inc. (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
Company Research Source: The Motley Fool
Investors had high expectations of the first clinical trial to edit the DNA of living humans, but they came away with concerns. Sangamo Therapeutics ( NASDAQ:SGMO ) made history on September 5 when it announced preliminary results from the first-ever clinical trial evaluating in vivo gene editing in humans, but the stock crashed, losing almost a quarter of its value that day. You would think from the market reaction that the trial was failure, but although the trial is not complete yet, so far, it's meeting the primary objective and two of the three secondary objectives. Is the market reaction an early indication that Sangamo's approach will end in disappointment? The CRISPR/Cas9 gene-editing technology has garnered a lot attention from investors because it is a relatively new and very powerful technique that has the potential to revolutionize medicine by making the discovery of gene-based therapies relatively cheap and easy. But Sangamo uses a technology called zinc Show less Read more
Impact Snapshot
Event Time:
SGMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SGMO alerts

from News Quantified
Opt-in for
SGMO alerts

from News Quantified